Order results by:
| Issue | Title | |
| Vol 14, No 3 (2021) | Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines | Abstract similar documents |
| I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva | ||
| "... of necessary medicines in the Samara Region in 2014–2017. Material and methods. The authors reviewed ..." | ||
| Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
| M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
| "... The purpose of our research was to analyze the actual practice of medicine in patients with breast ..." | ||
| Vol 12, No 3 (2019) | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support | Abstract similar documents |
| E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov | ||
| "... medicines and the manufacturing countries related to “The Program for Providing Essential Medicines ..." | ||
| Vol 12, No 1 (2019) | Effective search for potentially innovative scientific results in medicine | Abstract similar documents |
| M. B. Khrustalev, A. A. Maksimova | ||
| "... Medicine is one of the most important and rapidly developing branches of science. Research ..." | ||
| Vol 12, No 1 (2019) | The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation | Abstract similar documents |
| N. I. Zhuravleva, L. C. Shubina, O. A. Sukhorukikh | ||
| "... and Methods. We analyzed the LE- and GR-scales that had been used in developing clinical guidelines up to 01.09.2017 ..." | ||
| Vol 12, No 3 (2019) | Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia | Abstract similar documents |
| V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina | ||
| "... related to the development and implementation of clinical guidelines in 2016-2017 in 12 countries from ..." | ||
| Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract similar documents |
| V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
| "... No. 871 from August 28, 2014 (with amendments from November 20, 2018). The authors analyzed the historical ..." | ||
| Vol 9, No 2 (2016) | PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION | Abstract similar documents |
| T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva | ||
| "... in particular of providing preferential medicines patients with сhronic obstructive pulmonary disease (COPD ..." | ||
| Vol 9, No 3 (2016) | MONITORING OF CONSUMER ATTITUDES TO MEDICINES | Abstract similar documents |
| N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka | ||
| "... Objective. Comparative analysis and monitoring of the population’s attitude to medicines through ..." | ||
| Vol 9, No 2 (2016) | GENDER FEATURES OF THE POPULATION'S ATTITUDE TO MEDICINES | Abstract similar documents |
| N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka | ||
| "... Objective. The study of gender features of attitudes visitors of pharmacies to medicines ..." | ||
| Vol 12, No 4 (2019) | Clinical and economic analysis of drug costs in a general hospital in 2014-2018 | Abstract similar documents |
| A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova | ||
| "... with a simultaneous analysis of case histories. Results. The analysis of drug purchases in 2014-2018 and the obtained ..." | ||
| Vol 17, No 1 (2024) | Compounding pharmacy regulations: experience of the Latvian pharmaceutical market | Abstract similar documents |
| D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| Vol 18, No 1 (2025) | The effectiveness of using artificial intelligence in clinical medicine | Abstract similar documents |
| D. I. Korabelnikov, A. I. Lamotkin | ||
| "... Objective: To examine the effectiveness of using artificial intelligence (AI) in clinical medicine ..." | ||
| Vol 11, No 4 (2018) | Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense | Abstract similar documents |
| D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy | ||
| Vol 14, No 1 (2021) | Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy | Abstract similar documents |
| V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov | ||
| "... of medicines in different countries and systems of healthcare. Material and methods. Based on the open-access ..." | ||
| Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract similar documents |
| A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
| Vol 15, No 1 (2022) | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom | Abstract similar documents |
| A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
| "... Objective: analysis of state regulation of prices and costs for the purchase of medicines (drugs ..." | ||
| Vol 9, No 2 (2016) | EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL | Abstract similar documents |
| I. V. Demko, N. V. Gordeeva, E. N. Bochanova, N. I. Golovina, A. Yu. Kraposhina, I. A. Soloveva, E. A. Sobko, T. V. Gaygolnik, S. V. Chubarova | ||
| "... in 2004, 2011 and 2014. The frequency analysis was applied to studying the structure of the carried-out ..." | ||
| Vol 7, No 4 (2014) | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY | Abstract similar documents |
| D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
| Vol 10, No 4 (2017) | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET | Abstract similar documents |
| V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva | ||
| Vol 15, No 2 (2022) | Improving the efficiency of the medicine provision system for patients with malignant neoplasms | Abstract similar documents |
| Yu. A. Agafonova, D. V. Fedyaev, A. V. Snegovoy, V. V. Omelyanovskiy | ||
| "... and the availability of effective medical care. The current approach of access to cancer medicines limits ..." | ||
| Vol 17, No 3 (2024) | Artificial intelligence: basic terms and concepts, the application in healthcare and clinical medicine | Abstract similar documents |
| A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin | ||
| "... medicine and healthcare, and to determine the prospects for its implementation to improve diagnosis ..." | ||
| Vol 11, No 2 (2018) | Current practice of organizing and financing the departmental healthcare system for the military in developed countries: a review | Abstract similar documents |
| T. P. Bezdenezhnykh, D. V. Lukyantseva | ||
| "... Departmental medicine as a Russian-specific healthcare system is currently subject to broad ..." | ||
| Vol 13, No 4 (2020) | Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard | Abstract similar documents |
| I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova | ||
| Vol 15, No 1 (2022) | The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies | Abstract similar documents |
| A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem | ||
| "... databases, a search was made for clinical and economic studies of medicines included in the HCN list ..." | ||
| Vol 17, No 2 (2024) | Artificial intelligence in healthcare and medicine: the history of key events, its significance for doctors, the level of development in different countries | Abstract similar documents |
| A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin, S. A. Livshitz, E. G. Perevalova | ||
| "... and practical application of artificial intelligence (AI) in the field of healthcare and medicine based ..." | ||
| Vol 7, No 4 (2014) | APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES | Abstract similar documents |
| V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova | ||
| "... of disease severity and treatment efficacy. In 2014, a pilot study was conducted in the Russian Federation ..." | ||
| Vol 14, No 1 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... approaches in disciplines related to both the health of individuals and populations (medicine ..." | ||
| Vol 15, No 1 (2022) | A systematic review of real-world clinical practice data in COVID-19: non-interventional studies | Abstract similar documents |
| S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov | ||
| Vol 5, No 1 (2012) | UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES | Abstract similar documents |
| A. Y. Kulikov, A. G. Voskanyan | ||
| "... access to essential medicines in the scopes of the UN «Millennium Development Goals». In particular ..." | ||
| Vol 7, No 1 (2014) | ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT | Abstract similar documents |
| M. A. Shapovalova, L. R. Koretskaya | ||
| Vol 12, No 2 (2019) | Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava | ||
| "... The subject of this article is the obvious crisis of evidence-based medicine in the 21st century ..." | ||
| Vol 14, No 4 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... in health-related disciplines (Medicine and Epidemiology). Report 3 summarizes historical milestones (ideas ..." | ||
| Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
| "... Objective: to study the characteristics of the population consumption of medicines ..." | ||
| Vol 10, No 2 (2017) | THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS | Abstract similar documents |
| V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko | ||
| "... Among the most important aspects of the health policy are the methods for pricing of medicines ..." | ||
| Vol 16, No 1 (2023) | Compounding pharmacy regulations: experience of the North American pharmaceutical market | Abstract similar documents |
| D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| Vol 15, No 4 (2022) | Historical milestones of the invention and use of placebo | Abstract similar documents |
| A. N. Koterov | ||
| "... (alternative) and esoteric medicine. It is indicated that the origins of the experimental placebo are exorcism ..." | ||
| Vol 14, No 3 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... -related disciplines (Medicine and Epidemiology). Report 2 provides a description of the wellknown James ..." | ||
| Vol 16, No 2 (2023) | New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma | Abstract similar documents |
| M. А. Sorokina, A. V. Rakhteenko, T. R. Grishina | ||
| Vol 18, No 1 (2025) | Trends in the industry of clinical trials | Abstract similar documents |
| S. S. Milovanov, V. V. Popov, N. V. Teplova | ||
| Vol 11, No 3 (2018) | What is the role of antineoplastic drug safety in reimbursement decision making? | Abstract similar documents |
| A. S. Kolbin, A. A. Kurylev | ||
| "... Rationale. From 2014 to 2017, the portion of antineoplastic drugs dossiers submitted ..." | ||
| Vol 11, No 3 (2018) | The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia | Abstract similar documents |
| V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina | ||
| Vol 13, No 2 (2020) | Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, N. P. Vanchakova, A. N. Galustyan, Zh. D. Kobalava, T. R. Grishina, A. N. Gromov, I. A. Ilovaiskaya, V. M. Kodentsova, A. G. Kalacheva, O. A. Limanova, V. A. Maksimov, S. I. Malyavskaya, E. V. Mozgovaya, N. I. Tapilskaya, K. V. Rudakov, V. A. Semenov | ||
| "... resources for finding original publications in basic and clinical medicine. Currently ..." | ||
| Vol 13, No 4 (2020) | Concept of value-based healthcare | Abstract similar documents |
| N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov | ||
| Vol 8, No 2 (2015) | ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA | Abstract similar documents |
| Elamin H. Elbasha, Elena Aleksandrovna Pyadushkina, Maria Vladimirovna Avxentyeva, Alexander Gennadievich Tolkushin, Maxim Yurievich Frolov | ||
| "... with recommendations of the Panel on Cost-effectiveness in Health and Medicine and with consideration of requirements ..." | ||
| Vol 14, No 2 (2021) | Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care | Abstract similar documents |
| D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh | ||
| "... ) and International Medicine Reference Piece Data. The data array was based on the fiscal data provided by pharmacies ..." | ||
| Vol 9, No 1 (2016) | MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 | Abstract similar documents |
| A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum | ||
| "... Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug ..." | ||
| Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
| G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
| "... (LPD) in the Russian Federation in 2016- 2017. Materials and methods. Treating physicians in 75 regions ..." | ||
| Vol 6, No 3 (2013) | THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT | Abstract similar documents |
| N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova | ||
| "... . Vast majority of medicines is prescribed and can not be used for self-treatment. The most commonly used ..." | ||
| Vol 15, No 1 (2022) | Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution | Abstract similar documents |
| O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov | ||
| "... for the reporting period of 2017–2018. We used the tools of ABC/VEN analysis and import substitution assessment ..." | ||
| 1 - 50 of 116 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
